MedTrace Logo

Stevens-Johnson Syndrome Antimicrobial

NCT00844038 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2009-02-13

No results posted yet for this study

Summary

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacterial infections and mainly the administration of medicines, in general painkillers and antibiotics. The objective of this work is report the emergence of ulcerative vesicle -bubble chronic disease in areas of lips, gum, tongue and genital mucous membrane in a 26 year-old patient, leucoderma and masculine gender, in treatment of breathing infection with sulfametoxazol-trimetropima, having been diagnosed as syndrome of Steven-Johnson.

Conditions

  • Stevens-Johnson Syndrome

Sponsors & Collaborators

  • University of Pernambuco

    lead OTHER

Principal Investigators

  • Edwaldo Dr Dourado, Doctor · University of Pernambuco

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2008-08-31
Completion
2008-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00844038 on ClinicalTrials.gov